Your browser doesn't support javascript.
loading
Validity of the Italian multiple sclerosis neuropsychological screening questionnaire.
Migliore, Simone; Landi, Doriana; Proietti, Francesca; D'Aurizio, Giulia; Squitieri, Ferdinando; Mataluni, Giorgia; Nicoletti, Carolina Gabri; Curcio, Giuseppe; Marfia, Girolama Alessandra.
  • Migliore S; Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy. sim.migliore@gmail.com.
  • Landi D; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Proietti F; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • D'Aurizio G; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Squitieri F; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
  • Mataluni G; Huntington and Rare Diseases Unit, Fondazione IRCCS Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy.
  • Nicoletti CG; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Curcio G; Multiple Sclerosis Clinical and Research Unit, Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy.
  • Marfia GA; Department of Biotechnological and Applied Clinical Sciences, University of L'Aquila, L'Aquila, Italy.
Neurol Sci ; 42(11): 4583-4589, 2021 Nov.
Article en En | MEDLINE | ID: mdl-33651198
ABSTRACT
The Multiple Sclerosis Neuropsychological Questionnaire (MSNQ) is a brief questionnaire useful for screening patients with multiple sclerosis (MS) at risk for cognitive impairment. It includes a patient self-assessment (MSNQ-p) and a section for the caregiver (informant) (MSNQ-i). This study's aim was to validate the Italian version of MSNQ and to compare MSNQ scores with Symbol Digit Modality Test (SDMT), Beck Depression Inventory (BDI), and Expanded Disability Status Scale (EDSS) score, measuring cognitive skills, mood status, and physical disability respectively. We enrolled 122 MS patients (and related caregivers) at MS center of Tor Vergata University Hospital of Rome. The final study sample consisted of 122 patients with MS (90 relapsing-remitting, 24 secondary progressive, and 8 primary progressive). Our results highlighted that MSNQ has a unidimensional factor structure. Correlational analyses found a good correlation between both versions (MSNQ-p and MSNQ-i) of the questionnaire. Both MSNQ-p and MSNQ-i were correlated with clinical variables, specifically with cognitive impairment, mood disorder, and with disability. The Italian version of MSNQ is reliable and useful as screening tool to identify MS patients at high risk of cognitive impairment.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Conocimiento / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Trastornos del Conocimiento / Esclerosis Múltiple Tipo de estudio: Diagnostic_studies / Etiology_studies / Prognostic_studies / Screening_studies Límite: Humans País como asunto: Europa Idioma: En Año: 2021 Tipo del documento: Article